Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast agent presented as a sterile injectable solution for intra‑arterial, intra‑articular or intrathecal use. It enhances X‑ray attenuation to improve visualization of vascular structures, joint spaces and cerebrospinal fluid during diagnostic imaging procedures.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, diagnostic centres and imaging clinics worldwide, ensuring consistent quality and regulatory conformity across global markets. The company adheres to stringent quality standards and provides comprehensive documentation for regulatory approval.

Iomeprol is employed in diagnostic imaging procedures that rely on enhanced X‑ray attenuation to visualize internal structures. - Angiographic imaging of blood vessels: provides high‑contrast visualization of arterial and venous anatomy for accurate assessment of vascular disease. - Intra‑articular imaging of joints: delineates joint spaces and cartilage surfaces, facilitating evaluation of degenerative or traumatic conditions. - Intrathecal imaging of cerebrospinal fluid spaces: enhances contrast within the spinal canal and ventricular system for detailed neuro‑radiologic studies.

Iomeprol may be associated with a range of adverse reactions, from mild and transient to severe and life‑threatening. Common Side Effects: - Warm sensation or flushing at the injection site. - Nausea or vomiting. - Metallic taste in the mouth. - Mild headache or dizziness. - Transient itching or urticaria. - Mild injection site pain. Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction, including bronchospasm and hypotension. - Acute kidney injury, particularly in patients with pre‑existing renal impairment. - Seizures or neurological disturbances. - Cardiac arrhythmias or myocardial infarction in high‑risk individuals. - Pulmonary edema.

When using Iomeprol, clinicians should observe specific precautions to minimize risk and ensure patient safety. - Assess renal function: evaluate serum creatinine and eGFR before administration. - Review iodine allergy history: avoid use in patients with known severe hypersensitivity to iodinated contrast. - Use the lowest effective dose: tailor volume to the specific imaging study. - Monitor vital signs: observe blood pressure, heart rate and oxygen saturation during and after injection. - Adjust or discontinue metformin: temporarily stop metformin in patients with impaired renal function to prevent lactic acidosis. - Store at ambient temperature: keep the product in its original container, protect from light and moisture, and do not freeze.

Iomeprol can interact with certain medications, altering its safety profile or the efficacy of concomitant drugs. Major Interactions (Avoid): - Metformin: risk of lactic acidosis; discontinue before and after contrast exposure in patients with reduced renal function. - Thyroid hormone therapy (levothyroxine): iodine load may affect thyroid hormone levels; monitor thyroid function tests. - Radioactive iodine therapy: iodinated contrast can interfere with subsequent radioiodine uptake; postpone imaging for several weeks. Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen, naproxen): increase risk of contrast‑induced nephropathy; ensure adequate hydration. - Diuretics (especially loop diuretics): may exacerbate renal impairment; monitor fluid balance. - ACE inhibitors or ARBs: potential additive effect on renal function; consider temporary suspension.